In Vitro Activity of Peptide Antibiotics in Combination With Other Antimicrobials on Extensively Drug-Resistant Acinetobacter baumannii in the Planktonic and Biofilm Cell

被引：6
作者：
Meng, Qianlin [1 ,2 ]
Lin, Fei [1 ,3 ]
Ling, Baodong [1 ,2 ]
机构：
[1] Chengdu Med Coll, Sichuan Prov Coll Key Lab Struct Specif Small Mol, Chengdu, Peoples R China
[2] Chengdu Med Coll, Sch Pharm, Chengdu, Peoples R China
[3] Chengdu Med Coll, Dept Pharm, Affiliated Hosp 1, Chengdu, Peoples R China
来源：
FRONTIERS IN PHARMACOLOGY | 2022年 / 13卷
基金：
中国国家自然科学基金;
关键词：
peptide antibiotics; antimicrobials; Acinetobacter baumannii; synergy; antibacterial; VANCOMYCIN; SYNERGY;
D O I：
10.3389/fphar.2022.890955
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Acinetobacter baumannii is one of the most dangerous opportunistic pathogens in the global health care setup. Its drug resistance and biofilm-forming capability are often associated with chronic infections that are difficult to treat. Therefore, the clinical treatments for highly drug-resistant A. baumannii are limited. Antimicrobial peptides are broad-spectrum antibacterial agents combined with antibiotics that minimize selective bacterial resistance and enhance antibacterial efficacy. The current study evaluated the synergistic antibacterial activities of clinically important peptide antibiotics combined with other antimicrobials against nine extensively drug-resistant A. baumannii strains in planktonic and biofilm cells in vitro. Polymyxin B and E combined with imipenem showed 100% synergy in the planktonic cell with the checkerboard. Moreover, polymyxin E with rifampicin and bacitracin with imipenem or meropenem showed 100% additive effects. In the biofilm cell, polymyxin B and E combined with azithromycin showed 100% synergy, when vancomycin with azithromycin, rifampicin, and bacitracin with azithromycin or rifampicin, and teicoplanin with tigecycline or rifampicin, all showed 100% additive effects. Therefore, peptide antibiotics combined with other antimicrobials have synergistic or additive effects on extensively drug-resistant A. baumannii in planktonic and biofilm cells. In addition, the combination of polymyxins with carbapenems or azithromycin could be an ideal therapy against extensively drug-resistant A. baumannii infections.
引用
收藏
页数：7
相关论文
共 37 条
[21]   Cell wall stress responses in Bacillus subtilis:: the regulatory network of the bacitracin stimulon [J].
Mascher, T ;
Margulis, NG ;
Wang, T ;
Ye, RW ;
Helmann, JD .
MOLECULAR MICROBIOLOGY, 2003, 50 (05) :1591-1604
[22]   Propranolol, chlorpromazine and diclofenac restore susceptibility of extensively drug-resistant (XDR)-Acinetobacter baumanniito fluoroquinolones [J].
Mohammed, Mostafa A. ;
Ahmed, Mohammed T. ;
Anwer, Bahaa E. ;
Aboshanab, Khaled M. ;
Aboulwafa, Mohammad M. .
PLOS ONE, 2020, 15 (08)
[23]   Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review [J].
Mulani, Mansura S. ;
Kamble, Ekta E. ;
Kumkar, Shital N. ;
Tawre, Madhumita S. ;
Pardesi, Karishma R. .
FRONTIERS IN MICROBIOLOGY, 2019, 10
[24]   Effects of sub-inhibitory concentrations of meropenem and tigecycline on the expression of genes regulating pili, efflux pumps and virulence factors involved in biofilm formation by Acinetobacter baumannii [J].
Navidifar, Tahereh ;
Amin, Mansour ;
Rashno, Mohammad .
INFECTION AND DRUG RESISTANCE, 2019, 12 :1099-1111
[25]   Colistin monotherapy versus colistin/rifampicin combination therapy in pneumonia caused by colistin-resistant Acinetobacter baumannii: A randomised controlled trial [J].
Park, Hye Jung ;
Cho, Jae Hwa ;
Kim, Hyung Jung ;
Han, Sang Hoon ;
Jeong, Seok Hoon ;
Byun, Min Kwang .
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2019, 17 :66-71
[26]   Azithromycin: Mechanisms of action and their relevance for clinical applications [J].
Parnham, Michael J. ;
Haber, Vesna Erakovic ;
Giamarellos-Bourboulis, Evangelos J. ;
Perletti, Gianpaolo ;
Verleden, Geert M. ;
Vos, Robin .
PHARMACOLOGY & THERAPEUTICS, 2014, 143 (02) :225-245
[27]   In vitro activity of biofilm inhibitors in combination with antibacterial drugs against extensively drug-resistant Acinetobacter baumannii [J].
Peng, Qin ;
Lin, Fei ;
Ling, Baodong .
SCIENTIFIC REPORTS, 2020, 10 (01)
[28]   Antibiofilm Peptides: Potential as Broad-Spectrum Agents [J].
Pletzer, Daniel ;
Hancock, Robert E. W. .
JOURNAL OF BACTERIOLOGY, 2016, 198 (19) :2572-2578
[29]   Differences in Biofilm Mass, Expression of Biofilm-Associated Genes, and Resistance to Desiccation between Epidemic and Sporadic Clones of Carbapenem-Resistant Acinetobacter baumannii Sequence Type 191 [J].
Selasi, Gati Noble ;
Nicholas, Asiimwe ;
Jeon, Hyejin ;
Na, Seok Hyeon ;
Kwon, Hyo Il ;
Kim, Yoo Jeong ;
Heo, Sang Taek ;
Oh, Man Hwan ;
Lee, Je Chul .
PLOS ONE, 2016, 11 (09)
[30]   Biofilm-Induced Antibiotic Resistance in Clinical Acinetobacter baumannii Isolates [J].
Shenkutie, Abebe Mekuria ;
Yao, Mian Zhi ;
Siu, Gilman Kit-hang ;
Wong, Barry Kin Chung ;
Leung, Polly Hang-mei .
ANTIBIOTICS-BASEL, 2020, 9 (11) :1-15
1234